Market Research Logo

Global Cardiac Biomarkers Market Analysis & Trends - Industry Forecast to 2027

Global Cardiac Biomarkers Market Analysis & Trends - Industry Forecast to 2027

The Global Cardiac Biomarkers Market is poised to grow strong during the forecast period 2017 to 2027.. Some of the prominent trends that the market is witnessing include rising use of cardiac biomarkers in poc testing, emerging cardiac biomarkers and technological advancements using cardiac biomarkers combinations.

Based on Product, market is segmented into Myocardial muscle Creatine Kinase (CK-MB), Troponins(T,I), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia-modified albumin (IMA), Heart-type Fatty Acid Binding Protein (H-FABP), LDH isoenzymes and Other Products. On the basis of Location of Testing, market is classified into Point of Care Testing and Laboratory Testing.

Depending on the Application the market is segmented by Atherosclerosis, Congestive Heart Failure (CHF), Acute Myocardial Infarction (AMI), Acute Coronary Syndrome (ACS), Cardiomyopathy, Ischemia, Myocarditis, Atrial Fibrillation and Other Applications.

Based on End-User, market is segmented into diagnostic laboratories and hospitals and clinics.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:
North America
- US
- Canada
- Mexico

Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia Pacific

Middle East
- Saudi Arabia
- UAE
- Rest of Middle East

Latin America
- Argentina
- Brazil
- Rest of Latin America

Rest of the World
- South Africa
- Others

Report Highlights:
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2027, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2027
- Market opportunities and recommendations for new investments


1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 Application Analysis
1.6 End User Analysis
1.7 Strategic Benchmarking
1.8 Opportunity Analysis
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Rising use of cardiac biomarkers in POC testing
3.1.2 Emerging cardiac biomarkers
3.1.3 Technological advancements using cardiac biomarkers combinations
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry
4 Cardiac Biomarkers Market, By Product
4.1 Myocardial muscle Creatine Kinase (CK-MB)
DATA TABLE Myocardial muscle Creatine Kinase (CK-MB) Market Forecast to 2027 (US$ MN)
4.2 Troponins(T,I)
DATA TABLE Troponins(T,I) Market Forecast to 2027 (US$ MN)
4.3 Myoglobin
DATA TABLE Myoglobin Market Forecast to 2027 (US$ MN)
4.4 Brain Natriuretic Peptide (BNPs) or NT-proBNP
DATA TABLE Brain Natriuretic Peptide (BNPs) or NT-proBNP Market Forecast to 2027 (US$ MN)
4.5 Ischemia-modified albumin (IMA)
DATA TABLE Ischemia-modified albumin (IMA) Market Forecast to 2027 (US$ MN)
4.6 Heart-type Fatty Acid Binding Protein (H-FABP)
DATA TABLE Heart-type Fatty Acid Binding Protein (H-FABP) Market Forecast to 2027 (US$ MN)
4.7 LDH isoenzymes
DATA TABLE LDH isoenzymes Market Forecast to 2027 (US$ MN)
4.8 Other Products
DATA TABLE Other Products Market Forecast to 2027 (US$ MN)
5 Cardiac Biomarkers Market, By Location of Testing
5.1 Point of Care Testing
DATA TABLE Point of Care Testing Market Forecast to 2027 (US$ MN)
5.2 Laboratory Testing
DATA TABLE Laboratory Testing Market Forecast to 2027 (US$ MN)
6 Cardiac Biomarkers Market, By Application
6.1 Atherosclerosis
DATA TABLE Atherosclerosis Market Forecast to 2027 (US$ MN)
6.2 Congestive Heart Failure (CHF)
DATA TABLE Congestive Heart Failure (CHF) Market Forecast to 2027 (US$ MN)
6.3 Acute Myocardial Infarction (AMI)
DATA TABLE Acute Myocardial Infarction (AMI) Market Forecast to 2027 (US$ MN)
6.4 Acute Coronary Syndrome (ACS)
DATA TABLE Acute Coronary Syndrome (ACS) Market Forecast to 2027 (US$ MN)
6.5 Cardiomyopathy
DATA TABLE Cardiomyopathy Market Forecast to 2027 (US$ MN)
6.6 Ischemia
DATA TABLE Ischemia Market Forecast to 2027 (US$ MN)
6.7 Myocarditis
DATA TABLE Myocarditis Market Forecast to 2027 (US$ MN)
6.8 Atrial Fibrillation
DATA TABLE Atrial Fibrillation Market Forecast to 2027 (US$ MN)
6.9 Other Applications
DATA TABLE Other Applications Market Forecast to 2027 (US$ MN)
7 Cardiac Biomarkers Market, By End-User
7.1 Diagnostic laboratories
DATA TABLE Diagnostic laboratories Market Forecast to 2027 (US$ MN)
7.2 Hospitals and clinics
DATA TABLE Hospitals and clinics Market Forecast to 2027 (US$ MN)
8 Cardiac Biomarkers Market, By Geography
8.1 North America
DATA TABLE North America Market Forecast by Countries to 2027 (US$ MN)
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
DATA TABLE Europe Market Forecast by Countries to 2027 (US$ MN)
8.2.1 Germany
8.2.2 U.K
8.2.3 Italy
8.2.4 France
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
DATA TABLE Asia Pacific Market Forecast by Countries to 2027 (US$ MN)
8.3.1 China
8.3.2 Japan
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Middle East
DATA TABLE Middle East Market Forecast by Countries to 2027 (US$ MN)
8.4.1 Saudi Arabia
8.4.2 UAE
8.4.3 Rest of Middle East
8.5 Latin America
DATA TABLE Latin America Market Forecast by Countries to 2027 (US$ MN)
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Rest of Latin America
8.6 Rest of the World (RoW)
DATA TABLE RoW Market Forecast by Countries to 2027 (US$ MN)
8.6.1 South Africa
8.6.2 Others
9 Key Player Activities
9.1 Acquisitions & Mergers
9.2 Agreements, Partnerships, Collaborations and Joint Ventures
9.3 Product Launch & Expansions
9.4 Other Activities
10 Leading Companies
10.1 Abbott laboratories
10.2 Siemens Healthcare
10.3 Roche Diagnostics Corporation
10.4 Thermo Fisher Scientific
10.5 Becton, Dickinson And Co.
10.6 Beckman Coulter
10.7 BioMerieux
10.8 Bio-Rad Laboratories
10.9 Randox laboratories
10.10 Boditech Med Inc.
10.11 Quidel Corporation
10.12 Ortho-Clinical Diagnostics, Inc.
10.13 BG Medicine, Inc.
10.14 Response Biomedical Corp
10.15 Trivitron Healthcare
10.16 Trinity Biotech
List of Tables
Table 1 Global Cardiac Biomarkers Market By Region, Market Forecast (2015-2027) (US $MN)
Table 2 Global Cardiac Biomarkers Market By Product, Market Forecast (2015-2027) (US $MN)
Table 3 Global Cardiac Biomarkers Market By Myocardial muscle Creatine Kinase (CK-MB), Market Forecast (2015-2027) (US $MN)
Table 4 Global Cardiac Biomarkers Market By Troponins(T,I), Market Forecast (2015-2027) (US $MN)
Table 5 Global Cardiac Biomarkers Market By Myoglobin, Market Forecast (2015-2027) (US $MN)
Table 6 Global Cardiac Biomarkers Market By Brain Natriuretic Peptide (BNPs) or NT-proBNP, Market Forecast (2015-2027) (US $MN)
Table 7 Global Cardiac Biomarkers Market By Ischemia-modified albumin (IMA), Market Forecast (2015-2027) (US $MN)
Table 8 Global Cardiac Biomarkers Market By Heart-type Fatty Acid Binding Protein (H-FABP), Market Forecast (2015-2027) (US $MN)
Table 9 Global Cardiac Biomarkers Market By LDH isoenzymes, Market Forecast (2015-2027) (US $MN)
Table 10 Global Cardiac Biomarkers Market By Other Products, Market Forecast (2015-2027) (US $MN)
Table 11 Global Cardiac Biomarkers Market By Location of Testing, Market Forecast (2015-2027) (US $MN)
Table 12 Global Cardiac Biomarkers Market By Point of Care Testing, Market Forecast (2015-2027) (US $MN)
Table 13 Global Cardiac Biomarkers Market By Laboratory Testing, Market Forecast (2015-2027) (US $MN)
Table 14 Global Cardiac Biomarkers Market By Application, Market Forecast (2015-2027) (US $MN)
Table 15 Global Cardiac Biomarkers Market By Atherosclerosis, Market Forecast (2015-2027) (US $MN)
Table 16 Global Cardiac Biomarkers Market By Congestive Heart Failure (CHF), Market Forecast (2015-2027) (US $MN)
Table 17 Global Cardiac Biomarkers Market By Acute Myocardial Infarction (AMI), Market Forecast (2015-2027) (US $MN)
Table 18 Global Cardiac Biomarkers Market By Acute Coronary Syndrome (ACS), Market Forecast (2015-2027) (US $MN)
Table 19 Global Cardiac Biomarkers Market By Cardiomyopathy, Market Forecast (2015-2027) (US $MN)
Table 20 Global Cardiac Biomarkers Market By Ischemia, Market Forecast (2015-2027) (US $MN)
Table 21 Global Cardiac Biomarkers Market By Myocarditis, Market Forecast (2015-2027) (US $MN)
Table 22 Global Cardiac Biomarkers Market By Atrial Fibrillation, Market Forecast (2015-2027) (US $MN)
Table 23 Global Cardiac Biomarkers Market By Other Applications, Market Forecast (2015-2027) (US $MN)
Table 24 Global Cardiac Biomarkers Market By End-User, Market Forecast (2015-2027) (US $MN)
Table 25 Global Cardiac Biomarkers Market By Diagnostic laboratories, Market Forecast (2015-2027) (US $MN)
Table 26 Global Cardiac Biomarkers Market By Hospitals and clinics, Market Forecast (2015-2027) (US $MN)
Table 27 North America Cardiac Biomarkers Market By Country, Market Forecast (2015-2027) (US $MN)
Table 28 North America Cardiac Biomarkers Market By Product, Market Forecast (2015-2027) (US $MN)
Table 29 North America Cardiac Biomarkers Market By Myocardial muscle Creatine Kinase (CK-MB), Market Forecast (2015-2027) (US $MN)
Table 30 North America Cardiac Biomarkers Market By Troponins(T,I), Market Forecast (2015-2027) (US $MN)
Table 31 North America Cardiac Biomarkers Market By Myoglobin, Market Forecast (2015-2027) (US $MN)
Table 32 North America Cardiac Biomarkers Market By Brain Natriuretic Peptide (BNPs) or NT-proBNP, Market Forecast (2015-2027) (US $MN)
Table 33 North America Cardiac Biomarkers Market By Ischemia-modified albumin (IMA), Market Forecast (2015-2027) (US $MN)
Table 34 North America Cardiac Biomarkers Market By Heart-type Fatty Acid Binding Protein (H-FABP), Market Forecast (2015-2027) (US $MN)
Table 35 North America Cardiac Biomarkers Market By LDH isoenzymes, Market Forecast (2015-2027) (US $MN)
Table 36 North America Cardiac Biomarkers Market By Other Products, Market Forecast (2015-2027) (US $MN)
Table 37 North America Cardiac Biomarkers Market By Location of Testing, Market Forecast (2015-2027) (US $MN)
Table 38 North America Cardiac Biomarkers Market By Point of Care Testing, Market Forecast (2015-2027) (US $MN)
Table 39 North America Cardiac Biomarkers Market By Laboratory Testing, Market Forecast (2015-2027) (US $MN)
Table 40 North America Cardiac Biomarkers Market By Application, Market Forecast (2015-2027) (US $MN)
Table 41 North America Cardiac Biomarkers Market By Atherosclerosis, Market Forecast (2015-2027) (US $MN)
Table 42 North America Cardiac Biomarkers Market By Congestive Heart Failure (CHF), Market Forecast (2015-2027) (US $MN)
Table 43 North America Cardiac Biomarkers Market By Acute Myocardial Infarction (AMI), Market Forecast (2015-2027) (US $MN)
Table 44 North America Cardiac Biomarkers Market By Acute Coronary Syndrome (ACS), Market Forecast (2015-2027) (US $MN)
Table 45 North America Cardiac Biomarkers Market By Cardiomyopathy, Market Forecast (2015-2027) (US $MN)
Table 46 North America Cardiac Biomarkers Market By Ischemia, Market Forecast (2015-2027) (US $MN)
Table 47 North America Cardiac Biomarkers Market By Myocarditis, Market Forecast (2015-2027) (US $MN)
Table 48 North America Cardiac Biomarkers Market By Atrial Fibrillation, Market Forecast (2015-2027) (US $MN)
Table 49 North America Cardiac Biomarkers Market By Other Applications, Market Forecast (2015-2027) (US $MN)
Table 50 North America Cardiac Biomarkers Market By End-User, Market Forecast (2015-2027) (US $MN)
Table 51 North America Cardiac Biomarkers Market By Diagnostic laboratories, Market Forecast (2015-2027) (US $MN)
Table 52 North America Cardiac Biomarkers Market By Hospitals and clinics, Market Forecast (2015-2027) (US $MN)
Table 53 Europe Cardiac Biomarkers Market By Country, Market Forecast (2015-2027) (US $MN)
Table 54 Europe Cardiac Biomarkers Market By Product, Market Forecast (2015-2027) (US $MN)
Table 55 Europe Cardiac Biomarkers Market By Myocardial muscle Creatine Kinase (CK-MB), Market Forecast (2015-2027) (US $MN)
Table 56 Europe Cardiac Biomarkers Market By Troponins(T,I), Market Forecast (2015-2027) (US $MN)
Table 57 Europe Cardiac Biomarkers Market By Myoglobin, Market Forecast (2015-2027) (US $MN)
Table 58 Europe Cardiac Biomarkers Market By Brain Natriuretic Peptide (BNPs) or NT-proBNP, Market Forecast (2015-2027) (US $MN)
Table 59 Europe Cardiac Biomarkers Market By Ischemia-modified albumin (IMA), Market Forecast (2015-2027) (US $MN)
Table 60 Europe Cardiac Biomarkers Market By Heart-type Fatty Acid Binding Protein (H-FABP), Market Forecast (2015-2027) (US $MN)
Table 61 Europe Cardiac Biomarkers Market By LDH isoenzymes, Market Forecast (2015-2027) (US $MN)
Table 62 Europe Cardiac Biomarkers Market By Other Products, Market Forecast (2015-2027) (US $MN)
Table 63 Europe Cardiac Biomarkers Market By Location of Testing, Market Forecast (2015-2027) (US $MN)
Table 64 Europe Cardiac Biomarkers Market By Point of Care Testing, Market Forecast (2015-2027) (US $MN)
Table 65 Europe Cardiac Biomarkers Market By Laboratory Testing, Market Forecast (2015-2027) (US $MN)
Table 66 Europe Cardiac Biomarkers Market By Application, Market Forecast (2015-2027) (US $MN)
Table 67 Europe Cardiac Biomarkers Market By Atherosclerosis, Market Forecast (2015-2027) (US $MN)
Table 68 Europe Cardiac Biomarkers Market By Congestive Heart Failure (CHF), Market Forecast (2015-2027) (US $MN)
Table 69 Europe Cardiac Biomarkers Market By Acute Myocardial Infarction (AMI), Market Forecast (2015-2027) (US $MN)
Table 70 Europe Cardiac Biomarkers Market By Acute Coronary Syndrome (ACS), Market Forecast (2015-2027) (US $MN)
Table 71 Europe Cardiac Biomarkers Market By Cardiomyopathy, Market Forecast (2015-2027) (US $MN)
Table 72 Europe Cardiac Biomarkers Market By Ischemia, Market Forecast (2015-2027) (US $MN)
Table 73 Europe Cardiac Biomarkers Market By Myocarditis, Market Forecast (2015-2027) (US $MN)
Table 74 Europe Cardiac Biomarkers Market By Atrial Fibrillation, Market Forecast (2015-2027) (US $MN)
Table 75 Europe Cardiac Biomarkers Market By Other Applications, Market Forecast (2015-2027) (US $MN)
Table 76 Europe Cardiac Biomarkers Market By End-User, Market Forecast (2015-2027) (US $MN)
Table 77 Europe Cardiac Biomarkers Market By Diagnostic laboratories, Market Forecast (2015-2027) (US $MN)
Table 78 Europe Cardiac Biomarkers Market By Hospitals and clinics, Market Forecast (2015-2027) (US $MN)
Table 79 Asia Pacific Cardiac Biomarkers Market By Country, Market Forecast (2015-2027) (US $MN)
Table 80 Asia Pacific Cardiac Biomarkers Market By Product, Market Forecast (2015-2027) (US $MN)
Table 81 Asia Pacific Cardiac Biomarkers Market By Myocardial muscle Creatine Kinase (CK-MB), Market Forecast (2015-2027) (US $MN)
Table 82 Asia Pacific Cardiac Biomarkers Market By Troponins(T,I), Market Forecast (2015-2027) (US $MN)
Table 83 Asia Pacific Cardiac Biomarkers Market By Myoglobin, Market Forecast (2015-2027) (US $MN)
Table 84 Asia Pacific Cardiac Biomarkers Market By Brain Natriuretic Peptide (BNPs) or NT-proBNP, Market Forecast (2015-2027) (US $MN)
Table 85 Asia Pacific Cardiac Biomarkers Market By Ischemia-modified albumin (IMA), Market Forecast (2015-2027) (US $MN)
Table 86 Asia Pacific Cardiac Biomarkers Market By Heart-type Fatty Acid Binding Protein (H-FABP), Market Forecast (2015-2027) (US $MN)
Table 87 Asia Pacific Cardiac Biomarkers Market By LDH isoenzymes, Market Forecast (2015-2027) (US $MN)
Table 88 Asia Pacific Cardiac Biomarkers Market By Other Products, Market Forecast (2015-2027) (US $MN)
Table 89 Asia Pacific Cardiac Biomarkers Market By Location of Testing, Market Forecast (2015-2027) (US $MN)
Table 90 Asia Pacific Cardiac Biomarkers Market By Point of Care Testing, Market Forecast (2015-2027) (US $MN)
Table 91 Asia Pacific Cardiac Biomarkers Market By Laboratory Testing, Market Forecast (2015-2027) (US $MN)
Table 92 Asia Pacific Cardiac Biomarkers Market By Application, Market Forecast (2015-2027) (US $MN)
Table 93 Asia Pacific Cardiac Biomarkers Market By Atherosclerosis, Market Forecast (2015-2027) (US $MN)
Table 94 Asia Pacific Cardiac Biomarkers Market By Congestive Heart Failure (CHF), Market Forecast (2015-2027) (US $MN)
Table 95 Asia Pacific Cardiac Biomarkers Market By Acute Myocardial Infarction (AMI), Market Forecast (2015-2027) (US $MN)
Table 96 Asia Pacific Cardiac Biomarkers Market By Acute Coronary Syndrome (ACS), Market Forecast (2015-2027) (US $MN)
Table 97 Asia Pacific Cardiac Biomarkers Market By Cardiomyopathy, Market Forecast (2015-2027) (US $MN)
Table 98 Asia Pacific Cardiac Biomarkers Market By Ischemia, Market Forecast (2015-2027) (US $MN)
Table 99 Asia Pacific Cardiac Biomarkers Market By Myocarditis, Market Forecast (2015-2027) (US $MN)
Table 100 Asia Pacific Cardiac Biomarkers Market By Atrial Fibrillation, Market Forecast (2015-2027) (US $MN)
Table 101 Asia Pacific Cardiac Biomarkers Market By Other Applications, Market Forecast (2015-2027) (US $MN)
Table 102 Asia Pacific Cardiac Biomarkers Market By End-User, Market Forecast (2015-2027) (US $MN)
Table 103 Asia Pacific Cardiac Biomarkers Market By Diagnostic laboratories, Market Forecast (2015-2027) (US $MN)
Table 104 Asia Pacific Cardiac Biomarkers Market By Hospitals and clinics, Market Forecast (2015-2027) (US $MN)
Table 105 Middle East Cardiac Biomarkers Market By Country, Market Forecast (2015-2027) (US $MN)
Table 106 Middle East Cardiac Biomarkers Market By Product, Market Forecast (2015-2027) (US $MN)
Table 107 Middle East Cardiac Biomarkers Market By Myocardial muscle Creatine Kinase (CK-MB), Market Forecast (2015-2027) (US $MN)
Table 108 Middle East Cardiac Biomarkers Market By Troponins(T,I), Market Forecast (2015-2027) (US $MN)
Table 109 Middle East Cardiac Biomarkers Market By Myoglobin, Market Forecast (2015-2027) (US $MN)
Table 110 Middle East Cardiac Biomarkers Market By Brain Natriuretic Peptide (BNPs) or NT-proBNP, Market Forecast (2015-2027) (US $MN)
Table 111 Middle East Cardiac Biomarkers Market By Ischemia-modified albumin (IMA), Market Forecast (2015-2027) (US $MN)
Table 112 Middle East Cardiac Biomarkers Market By Heart-type Fatty Acid Binding Protein (H-FABP), Market Forecast (2015-2027) (US $MN)
Table 113 Middle East Cardiac Biomarkers Market By LDH isoenzymes, Market Forecast (2015-2027) (US $MN)
Table 114 Middle East Cardiac Biomarkers Market By Other Products, Market Forecast (2015-2027) (US $MN)
Table 115 Middle East Cardiac Biomarkers Market By Location of Testing, Market Forecast (2015-2027) (US $MN)
Table 116 Middle East Cardiac Biomarkers Market By Point of Care Testing, Market Forecast (2015-2027) (US $MN)
Table 117 Middle East Cardiac Biomarkers Market By Laboratory Testing, Market Forecast (2015-2027) (US $MN)
Table 118 Middle East Cardiac Biomarkers Market By Application, Market Forecast (2015-2027) (US $MN)
Table 119 Middle East Cardiac Biomarkers Market By Atherosclerosis, Market Forecast (2015-2027) (US $MN)
Table 120 Middle East Cardiac Biomarkers Market By Congestive Heart Failure (CHF), Market Forecast (2015-2027) (US $MN)
Table 121 Middle East Cardiac Biomarkers Market By Acute Myocardial Infarction (AMI), Market Forecast (2015-2027) (US $MN)
Table 122 Middle East Cardiac Biomarkers Market By Acute Coronary Syndrome (ACS), Market Forecast (2015-2027) (US $MN)
Table 123 Middle East Cardiac Biomarkers Market By Cardiomyopathy, Market Forecast (2015-2027) (US $MN)
Table 124 Middle East Cardiac Biomarkers Market By Ischemia, Market Forecast (2015-2027) (US $MN)
Table 125 Middle East Cardiac Biomarkers Market By Myocarditis, Market Forecast (2015-2027) (US $MN)
Table 126 Middle East Cardiac Biomarkers Market By Atrial Fibrillation, Market Forecast (2015-2027) (US $MN)
Table 127 Middle East Cardiac Biomarkers Market By Other Applications, Market Forecast (2015-2027) (US $MN)
Table 128 Middle East Cardiac Biomarkers Market By End-User, Market Forecast (2015-2027) (US $MN)
Table 129 Middle East Cardiac Biomarkers Market By Diagnostic laboratories, Market Forecast (2015-2027) (US $MN)
Table 130 Middle East Cardiac Biomarkers Market By Hospitals and clinics, Market Forecast (2015-2027) (US $MN)
Table 131 Latin America Cardiac Biomarkers Market By Country, Market Forecast (2015-2027) (US $MN)
Table 132 Latin America Cardiac Biomarkers Market By Product, Market Forecast (2015-2027) (US $MN)
Table 133 Latin America Cardiac Biomarkers Market By Myocardial muscle Creatine Kinase (CK-MB), Market Forecast (2015-2027) (US $MN)
Table 134 Latin America Cardiac Biomarkers Market By Troponins(T,I), Market Forecast (2015-2027) (US $MN)
Table 135 Latin America Cardiac Biomarkers Market By Myoglobin, Market Forecast (2015-2027) (US $MN)
Table 136 Latin America Cardiac Biomarkers Market By Brain Natriuretic Peptide (BNPs) or NT-proBNP, Market Forecast (2015-2027) (US $MN)
Table 137 Latin America Cardiac Biomarkers Market By Ischemia-modified albumin (IMA), Market Forecast (2015-2027) (US $MN)
Table 138 Latin America Cardiac Biomarkers Market By Heart-type Fatty Acid Binding Protein (H-FABP), Market Forecast (2015-2027) (US $MN)
Table 139 Latin America Cardiac Biomarkers Market By LDH isoenzymes, Market Forecast (2015-2027) (US $MN)
Table 140 Latin America Cardiac Biomarkers Market By Other Products, Market Forecast (2015-2027) (US $MN)
Table 141 Latin America Cardiac Biomarkers Market By Location of Testing, Market Forecast (2015-2027) (US $MN)
Table 142 Latin America Cardiac Biomarkers Market By Point of Care Testing, Market Forecast (2015-2027) (US $MN)
Table 143 Latin America Cardiac Biomarkers Market By Laboratory Testing, Market Forecast (2015-2027) (US $MN)
Table 144 Latin America Cardiac Biomarkers Market By Application, Market Forecast (2015-2027) (US $MN)
Table 145 Latin America Cardiac Biomarkers Market By Atherosclerosis, Market Forecast (2015-2027) (US $MN)
Table 146 Latin America Cardiac Biomarkers Market By Congestive Heart Failure (CHF), Market Forecast (2015-2027) (US $MN)
Table 147 Latin America Cardiac Biomarkers Market By Acute Myocardial Infarction (AMI), Market Forecast (2015-2027) (US $MN)
Table 148 Latin America Cardiac Biomarkers Market By Acute Coronary Syndrome (ACS), Market Forecast (2015-2027) (US $MN)
Table 149 Latin America Cardiac Biomarkers Market By Cardiomyopathy, Market Forecast (2015-2027) (US $MN)
Table 150 Latin America Cardiac Biomarkers Market By Ischemia, Market Forecast (2015-2027) (US $MN)
Table 151 Latin America Cardiac Biomarkers Market By Myocarditis, Market Forecast (2015-2027) (US $MN)
Table 152 Latin America Cardiac Biomarkers Market By Atrial Fibrillation, Market Forecast (2015-2027) (US $MN)
Table 153 Latin America Cardiac Biomarkers Market By Other Applications, Market Forecast (2015-2027) (US $MN)
Table 154 Latin America Cardiac Biomarkers Market By End-User, Market Forecast (2015-2027) (US $MN)
Table 155 Latin America Cardiac Biomarkers Market By Diagnostic laboratories, Market Forecast (2015-2027) (US $MN)
Table 156 Latin America Cardiac Biomarkers Market By Hospitals and clinics, Market Forecast (2015-2027) (US $MN)
Table 157 Rest of the World (RoW) Cardiac Biomarkers Market By Country, Market Forecast (2015-2027) (US $MN)
Table 158 Rest of the World (RoW) Cardiac Biomarkers Market By Product, Market Forecast (2015-2027) (US $MN)
Table 159 Rest of the World (RoW) Cardiac Biomarkers Market By Myocardial muscle Creatine Kinase (CK-MB), Market Forecast (2015-2027) (US $MN)
Table 160 Rest of the World (RoW) Cardiac Biomarkers Market By Troponins(T,I), Market Forecast (2015-2027) (US $MN)
Table 161 Rest of the World (RoW) Cardiac Biomarkers Market By Myoglobin, Market Forecast (2015-2027) (US $MN)
Table 162 Rest of the World (RoW) Cardiac Biomarkers Market By Brain Natriuretic Peptide (BNPs) or NT-proBNP, Market Forecast (2015-2027) (US $MN)
Table 163 Rest of the World (RoW) Cardiac Biomarkers Market By Ischemia-modified albumin (IMA), Market Forecast (2015-2027) (US $MN)
Table 164 Rest of the World (RoW) Cardiac Biomarkers Market By Heart-type Fatty Acid Binding Protein (H-FABP), Market Forecast (2015-2027) (US $MN)
Table 165 Rest of the World (RoW) Cardiac Biomarkers Market By LDH isoenzymes, Market Forecast (2015-2027) (US $MN)
Table 166 Rest of the World (RoW) Cardiac Biomarkers Market By Other Products, Market Forecast (2015-2027) (US $MN)
Table 167 Rest of the World (RoW) Cardiac Biomarkers Market By Location of Testing, Market Forecast (2015-2027) (US $MN)
Table 168 Rest of the World (RoW) Cardiac Biomarkers Market By Point of Care Testing, Market Forecast (2015-2027) (US $MN)
Table 169 Rest of the World (RoW) Cardiac Biomarkers Market By Laboratory Testing, Market Forecast (2015-2027) (US $MN)
Table 170 Rest of the World (RoW) Cardiac Biomarkers Market By Application, Market Forecast (2015-2027) (US $MN)
Table 171 Rest of the World (RoW) Cardiac Biomarkers Market By Atherosclerosis, Market Forecast (2015-2027) (US $MN)
Table 172 Rest of the World (RoW) Cardiac Biomarkers Market By Congestive Heart Failure (CHF), Market Forecast (2015-2027) (US $MN)
Table 173 Rest of the World (RoW) Cardiac Biomarkers Market By Acute Myocardial Infarction (AMI), Market Forecast (2015-2027) (US $MN)
Table 174 Rest of the World (RoW) Cardiac Biomarkers Market By Acute Coronary Syndrome (ACS), Market Forecast (2015-2027) (US $MN)
Table 175 Rest of the World (RoW) Cardiac Biomarkers Market By Cardiomyopathy, Market Forecast (2015-2027) (US $MN)
Table 176 Rest of the World (RoW) Cardiac Biomarkers Market By Ischemia, Market Forecast (2015-2027) (US $MN)
Table 177 Rest of the World (RoW) Cardiac Biomarkers Market By Myocarditis, Market Forecast (2015-2027) (US $MN)
Table 178 Rest of the World (RoW) Cardiac Biomarkers Market By Atrial Fibrillation, Market Forecast (2015-2027) (US $MN)
Table 179 Rest of the World (RoW) Cardiac Biomarkers Market By Other Applications, Market Forecast (2015-2027) (US $MN)
Table 180 Rest of the World (RoW) Cardiac Biomarkers Market By End-User, Market Forecast (2015-2027) (US $MN)
Table 181 Rest of the World (RoW) Cardiac Biomarkers Market By Diagnostic laboratories, Market Forecast (2015-2027) (US $MN)
Table 182 Rest of the World (RoW) Cardiac Biomarkers Market By Hospitals and clinics, Market Forecast (2015-2027) (US $MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report